From the Lumea Podcast - Ask A Pathologist:  Welcome to our seventh episode of the Ask a Pathologist Podcast, Innovators in Action. We had the privilege to interview Dr. Todd Randolph about artificial intelligence and its current and future...

Lumea, dedicated to advancing tissue standardization and digital pathology, solidified its position in the United States in the latest KLAS Research LEHI, UTAH, USA, February 8, 2024 /EINPresswire.com/ — Lumea, a trailblazing digital...

From the Lumea Podcast - Ask A Pathologist: In our fifth Ask a Pathologist Podcast episode we had the privilege to interview Dr. Hillel Kahane about his favorite game-changing tools for pathologists. From pre-analytical tools to digital...

Lumea: Enabling pathologists to use cutting-edge diagnostic solutions for decision support in Gleason grading prostate cancer specimens. LEHI, UTAH, USA, December 7, 2023 /EINPresswire.com/ -- Lumea Inc., a leader in integrated digital...

Lumea: The FDA's recent move to treat Laboratory Developed Tests (LDTs) as medical devices has sent ripples through the industry. With the absence of a passed legislation in 2022, the FDA has taken a pivotal step, emphasizing its...

Lumea, a leader in digital pathology solutions, has chosen Tempus, a leader in artificial intelligence and precision medicine, to create AI-enabled solutions LEHI, UTAH, UNITED STATES, August 4, 2022 /EINPresswire.com/ -- Lumea Inc, a leader...